seed
Stage
About
Antigenix Therapeutics develops antibody-based therapies for cancer treatment, focusing on targeted antibody-drug conjugate therapies to improve the precision and effectiveness against aggressive and treatment-resistant cancers.
Explore Antigenix Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.